講師資料
Talks：
Enhancing PAP Clinical Outcomes Through Connected Care, Digital Health, and Personalized Treatment
Name：
Professor Peter Cistulli
Position：
Professor of Sleep Medicine, President-Elect of World Sleep Society
Affiliation：
1. Charles Perkins Centre and Sydney Medical School, The University of Sydney, Camperdown, Sydney, Australia
2. Department of Respiratory and Sleep Medicine, Royal North Shore Hospital, St Leonards, Sydney, Australia
Email：
Photo：
Research Interests：
Precision Sleep Medicine, Obstructive Sleep Apnoea, Sleep Disorders
Selected Publications：
1. Flood JM, Cistulli PA, Tong BK, Mohammadieh A, de Chazal P, Stewart GM. Current and novel device-led approaches for targeted obstructive sleep apnea screening, diagnosis, treatment, and long-term management. Expert Rev Med Devices. 2026;23(3):303–319. doi:10.1080/17434440.2026.2625362.
2. Drager LF, Malhotra A, Yan Y, Pépin JL, Armitstead JP, Woehrle H, Nunez CM, Cistulli PA, Benjafield AV; medXcloud group. Adherence with positive airway pressure therapy for obstructive sleep apnea in developing vs. developed countries: a big data study. J Clin Sleep Med. 2021;17(4):703–709. doi:10.5664/jcsm.9008.
3. Cistulli PA, Armitstead JP, Malhotra A, et al. Relationship between Self-reported Sleepiness and Positive Airway Pressure Treatment Adherence in Obstructive Sleep Apnea. Ann Am Thorac Soc. 2023;20(8):1201–1209. doi:10.1513/AnnalsATS.202206-482OC.
Abstract：
Positive airway pressure (PAP) therapy remains a cornerstone of treatment for obstructive sleep apnea, but achieving optimal clinical outcomes requires more than prescribing an effective device. Early experiences with therapy, treatment-related side effects, patient engagement, and timely clinical support can strongly influence long-term use and effectiveness.
Connected PAP platforms and digital health technologies are creating opportunities to move from episodic follow-up toward more proactive, data-informed care. Remote monitoring can identify problems such as mask leak, residual respiratory events, pressure intolerance, and declining usage, while patient-facing applications, digital education, and telehealth can support engagement and facilitate earlier, targeted intervention.
This presentation will examine how connected care can be integrated into clinical pathways to support PAP initiation and long-term management. It will also explore how device-derived data, clinical information, and patient-reported experience can be combined to personalise treatment and support, with the goal of improving adherence, therapeutic effectiveness, patient experience, and efficiency of care.
2026年會：